These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4117669)

  • 1. Heredopathia atactica polyneuritiformis (Refsum's disease). Experiences of dietary treatment and plasmapheresis.
    Lundberg A; Lilja LG; Lundberg PO; Try K
    Eur Neurol; 1972; 8(6):309-24. PubMed ID: 4117669
    [No Abstract]   [Full Text] [Related]  

  • 2. Heredopathia atactica polyneuritiformis (Refsum's Disease): a second trial of dietary therapy in two patients.
    Kark RA; Engel WK; Blass JP; Steinberg D; Walsh GO
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):53-5. PubMed ID: 4141911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the biochemical defect in heredopathia atactica polyneuritiformis (Refsum's disease).
    Eldjarn L; Try K; Stokke O
    Pathol Eur; 1968; 3(2):459-67. PubMed ID: 4176999
    [No Abstract]   [Full Text] [Related]  

  • 4. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional and metabolic aspects of heredopathia atactica polyneuritiformis (Refsum's syndrome).
    Lenk W
    Nutr Metab; 1974; 16(6):366-74. PubMed ID: 4135766
    [No Abstract]   [Full Text] [Related]  

  • 6. Heredopathia atactica polyneuritiformis, biochemical defect and dietary treatment.
    Eldjarn L; Try K; Stokke O; Munthe-Kaas AW; Refsum S
    Acta Neurol Scand; 1967; 43(S31):61-2. PubMed ID: 4171040
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).
    Harari D; Gibberd FB; Dick JP; Sidey MC
    J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):614-7. PubMed ID: 1716665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HEREDOPATHIA ATACTICA POLYNEURITIFORMIS. CLINICAL ASPECTS AND DIAGNOSIS OF THE REFSUM SYNDROME].
    HARDERS H; DIECKMANN H
    Dtsch Med Wochenschr; 1964 Feb; 89():248-54. PubMed ID: 14158992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pauci-symptomatic sensory polyneuropathy in Refsum's disease].
    Lévy R; Verny M; Brault JL; Gugenheim M; Maisonobe T; Léger JM
    Rev Neurol (Paris); 1996; 152(6-7):469-72. PubMed ID: 8944245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of thin-layer chromatography for the preliminary diagnosis of Refsum's disease (Heredopathia atactica polyneuritiformis).
    Karlsson KA; Norrby A; Samuelsson B
    Biochim Biophys Acta; 1967 Aug; 144(1):162-4. PubMed ID: 4168043
    [No Abstract]   [Full Text] [Related]  

  • 11. Heredopathia atactica polyneuritiformis (Refsum's diseases). An audiological examination of two patients.
    Bergsmark J; Djupesland G
    Eur Neurol; 1968; 1(2):122-30. PubMed ID: 4177049
    [No Abstract]   [Full Text] [Related]  

  • 12. Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.
    Steinberg D; Mize CE; Herndon JH; Fales HM; Engel WK; Vroom FQ
    Arch Intern Med; 1970 Jan; 125(1):75-87. PubMed ID: 4188898
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term plasma exchange in a case of Refsum's disease.
    Leppert D; Schanz U; Burger J; Gmür J; Blau N; Waespe W
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):82-4. PubMed ID: 1718440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heredopathia atactica polyneuritiformis. Hexadecanoic acid storage disease (Refsum's disease). Definition, treatment and pathogenesis. A short review].
    Refsum S
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():11-8. PubMed ID: 95656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEREDOPATHIA ATACTICA POLYNEURITIFORMIS (REFSUM'S DISEASE)--A DEFECT IN THE OMEGA-OXIDATION MECHANISM OF FATTY ACIDS.
    ELDJARN L
    Scand J Clin Lab Invest; 1965; 17():178-81. PubMed ID: 14285926
    [No Abstract]   [Full Text] [Related]  

  • 16. Dietary effects on serum-phytanic-acid levels and on clinical manifestations in heredopathia atactica polyneuritiformis.
    Eldjarn L; Try K; Stokke O; Munthe-Kaas AW; Refsum S; Steinberg D; Avigan J; Mize C
    Lancet; 1966 Mar; 1(7439):691-3. PubMed ID: 4159604
    [No Abstract]   [Full Text] [Related]  

  • 17. Refsum's syndrome. Heredopathia atactica polyneuritiformis.
    Nevin NC; Cumings JN; McKeown F
    Brain; 1967 Jun; 90(2):419-28. PubMed ID: 4165695
    [No Abstract]   [Full Text] [Related]  

  • 18. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)].
    Feldmann H
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refsum's disease: long term treatment preserves sensory nerve action potentials and motor function.
    Lou JS; Snyder R; Griggs RC
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):671-2. PubMed ID: 9219766
    [No Abstract]   [Full Text] [Related]  

  • 20. [Refsum's disease: evolution 35 years after diagnosis].
    Marcaud V; Defontaines B; Jung P; Degos CF
    Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.